Rankings
▼
Calendar
GUTS Q4 2024 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
GUTS
Fractyl Health, Inc. Common Stock
$35M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3,000
-57.1% YoY
Gross Profit
$3,000
100.0% margin
Operating Income
-$25M
-840333.3% margin
Net Income
-$25M
-832333.3% margin
EPS (Diluted)
$-0.51
QoQ Revenue Growth
-78.6%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$108M
Total Liabilities
$80M
Stockholders' Equity
$28M
Cash & Equivalents
$67M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3,000
$7,000
-57.1%
Gross Profit
$3,000
$5,000
-40.0%
Operating Income
-$25M
-$13M
-94.2%
Net Income
-$25M
-$19M
-30.2%
← FY 2024
All Quarters
Q1 2025 →